TrialThe Journal of infectious diseases2012

Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials.

David C Montefiori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.